Japanese Biotech Startup bitBiome Raises US$6.6M Series B

bitBiome aims to boost its genomics platform bit-MAP with the fresh round of funding

Japanese microbiome analytics company bitBiome has secured a funding of JPY700 million (around US$6.6 million) in its Series B financing, the company announced in a statement today.

The fresh capital was raised from Universal Materials Incubator, a venture capital firm specializing in materials and chemical industry investments, IDATEN Ventures, a seed and early-stage venture investor, and Vital Ventures, the statement noted. Existing backer The University of Tokyo Edge Capital Partners (UTEC) also joined the round.

With the Series B round, bitBiome’s capital haul now stands at JPY1.05 billion (around US$10 million), according to the company. The funds will be utilized towards backing up the company’s proprietary microbe-focused single-cell genomics platform bit-MAP.

Specifically, the funding will enable a large-scale study by bitBiome on patient samples, collected in collaboration with Japanese clinical solutions provider QLife, for over 20 diseases.

These include cancer, intestinal diseases, autoimmune diseases, and neuropsychiatric disorders amongst others. The company’s bit-MAP platform aims to deeply analyse the relationship between oral and gut microbes and these disease states.

The statement noted that bitBiome will also be channelling the funds towards R&D efforts, investment in lab equipment, growing its global business, acquiring and maintaining intellectual property, and hiring efforts.

bitBiome also has corporate and academic partnerships in the pipelines for research on drug or biomarkers (pathological indicators) discovery, and access to data, the company said in the statement.

Partner at UTEC Atsushi Usami noted in the statement that bitBiome’s technology is able to extract comprehensive and accurate genetic information from a single microbe.

“Based on this highly accurate microbial genome database, bitBiome is providing services to create new therapeutics, diagnostics, industrial enzymes and other useful substances, as well as to elucidate the mechanisms of diseases and medicinal effects,” he said.

bitBiome was spun out of Tokyo’s Waseda University in November 2018. The company had earlier announced that it had received JPY350 million in funding from UTEC in January 2019.

Since then, the company has been beefing up its technological and operational capabilities.

Apart from bolstering business development, R&D, and administration through fresh hires and purchase of lab facilities, the company has filed for eight international patents so far, the statement noted.

It has also enhanced its bioinformatics capabilities, the statement said, by expanding the number of single cells that can be analyzed per month from 2000 to over 20,000 genomes.

“We expect that this funding will enable the company to further contribute to the development of the biotechnology industry and medical care through the participation of more commercialization members and global business expansion,” Atsushi noted in the statement.

Header image by wirestock on Freepik

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

Is Using AI for Academic Writing Cheating?

Is Using AI for Academic Writing Cheating?

From films written and directed by ChatGPT to Kindle authors writing books with artificial intelligence (AI), we are seeing more and more reportage on AI writing tools these days. While writing with an AI may seem harmless and possibly helps improve work efficiency, the use of these tools in the sphere of academic writing has generated serious concern. Teachers are worried that the use of AI writing tools is equivalent to plagiarism or cheating.

7 Creative Ways to Reward Employees without a Salary Raise

7 Creative Ways to Reward Employees without a Salary Raise

Giving your employees a raise is a significant way to show your employees that you value their work and compensate them appropriately for their contributions. Failing to acknowledge the work of your employees can be ‌costly for startups. A OnePoll survey of 2,000 workers found that almost half of ‌American workers (46%) have quit a job due to feeling unrecognized

The Pros and Cons of Human Cloning

The Pros and Cons of Human Cloning

Clones, human or otherwise, are genetically identical copies of a living organism produced artificially in a laboratory. Over the years, many animals have been cloned. Starting from the cloning of a tadpole in 1952 to the cloning of a sheep named Dolly from adult mammal cells in 1996, cloning has come a long way.

Reform of Hong Kong's Offshore Tax System

Reform of Hong Kong’s Offshore Tax System

Further to the introduction of the proposed Hong Kong’s new Foreign-Source Income Exemption (FSIE) regime as discussed in our article A Challenge to Hong Kong’s Long-Established Offshore Tax System in October 2022, the relevant legislation has been enacted and became effective on January 1, 2023.

Mark Cuban’s Tips on How to Get Rich

Mark Cuban’s Tips on How to Get Rich

A popular adage suggests, money makes the world go round. People are always looking to do better financially so that their lives can be more secure. To make that happen, some seek out the advice of millionaires—the ones who have been there, done that.

What India's EdTech Industry Must Prioritize in 2023?

What India’s EdTech Industry Must Prioritize in 2023?

2022 was a tough year for the majority of education technology (EdTech) in India, with the “Tracxn Geo Annual Report: India Tech 2022” reporting a 39 per cent decrease in funding during the January-November period compared to 2021. To overcome this, many businesses, including industry-leading players like BYJU’S, Unacademy and Vedantu, had to resort to job cuts.